Mark McDade, Director at Aimmune Therapeutics, Inc. (AIMT), bought 16,660 shares at $16.00 ($267K) on 2015-08-11, disclosed to the SEC on 2015-08-11.
Open-market purchase of $267k AIMT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| PrivatePHILLIPS EDISON GROCERY CENTER REIT II, INC. | BUY | 2015-07-17 | $9K | — | Filing → |
| PrivatePHILLIPS EDISON GROCERY CENTER REIT II, INC. | BUY | 2015-05-08 | $9K | — | Filing → |
| PDLI | SELL | 2007-01-19 | $215K | — | Filing → |